Cerebrovascular disease, the apolipoprotein e4 allele, and cognitive decline in a community-based study of elderly men

Stroke

Volumn 27, Issue 12, 1996, Pages 2230-2235

  Kalmijn, S ^a,b,c,d   Feskens, E J M ^a   Launer, L J ^a,b   Kromhout, D ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Netherlands Institute for Health Sciences   (Netherlands)

^d NONE   (Netherlands)

Author keywords

apolipoproteins; cerebrovascular disorders; cognition; dementia

Indexed keywords

APOLIPOPROTEIN E4;

AGED; ARTICLE; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; HUMAN; ISCHEMIC HEART DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL TEST; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030453774     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.12.2230     Document Type: Article

References (40)

1. Erkinjuntti T, Hachinski VC. Rethinking vascular dementia. Cerebrovasc Dis. 1993;3:3-23.
2. Breteler MMB, Claus JJ, Grobbee DE, Hofman A. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. Br Med J. 1994;308:1604-1608.
3. Gorelick PB, Brody J, Cohen D, Freels S, Levy P, Dollear W, Forman H, Harris Y. Risk factors for dementia associated with multiple cerebral infarcts: a case-control analysis in predominantly African-American hospital-based patients. Arch Neurol. 1993;50:714-720.
4. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ. The association between midlife blood pressure levels and late-life cognitive function. JAMA. 1995;274:1846-1851.
5. Breteler MMB, van Swielen JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JHW, van Harskamp F, Tanghe HLJ, de Jong PTVM, van Gijn J, Hofman A. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology. 1994;44:1246-1252.
6. Van Swieten JC, Geyskes GG, Derix MA, Peeck BM, Ramos LMP, van Latum JC, van Gijn J. Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol. 1991; 30:825-830.
7. Kalmijn S, Feskens EJM, Launer LJ, Stijnen T, Kromhout D. Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetologia. 1995;38:1096-1102.
8. Walzl M, Lechner H, Walzl B, Schied G. Improved neurological recovery of cerebral infarctions after plasmapheretic reduction of lipids and fibrinogen. Stroke. 1993;24:1447-1451.
9. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993;261:921-923.
10. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90:1977-1981.
11. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 1993;342:697-699.
12. Feskens EJM, Havekes LM, Kalmijn S, de Knijff P, Launer LJ, Kromhout D. Apolipoprotein e4 allele and cognitive decline in elderly men. Br Med J. 1994;309:1202-1206.
13. Reed T, Carmelli D, Swan GE, Breitner JCS, Welsh KA, Jarvik GP, Deeb S, Auwerx J. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E e4 allele. Arch Neurol. 1994;51:1189-1192.
14. Henderson AS, Easteal S, Jorm AF, Mackinnon AJ, Korten AE, Christensen H, Croft L, Jacomb PA. Apolipoprotein E allele ε4, dementia, and cognitive decline in a population sample. Lancet. 1995; 346:1387-1390.
15. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988;8:1-21.
16. Kuusi T, Nieminen MS, Ehnholm C, Yki-Jarvinen H, Valle M, Nikkila EA, Taskinen M-R. Apolipoprotein E polymorphism and coronary artery disease: increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients. Arteriosclerosis. 1989;9: 237-241.
17. van Bockxmeer FM, Mamotte CDS. Apolipoprotein ε4 homozygosity in young men with coronary heart disease. Lancet. 1992; 340:879-880.
18. Pedro-Botet J, Senti M, Nogués X, Rubies-Prat J, Roquer J, D'Olhaberriague L, Olive J. Lipoprotein and apolipoprotein profile in men with ischemic stroke: role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke. 1992;23: 1556-1562.
19. Feskens EJM, Weijenberg MP, Kromhout D. A longitudinal study on diet, risk factors and cardiovascular disease in an aging cohort: the Zutphen Study. Neth J Cardiol. 1993;4:200-204.
20. Keys A, Aravanis C, Blackburn HW, Buzina R, Djordjevic BS, Dontas AS, Fidanza F, Karvonen MJ, Kimura N, Menotti A, Mohacek I, Nedeljkovic S, Puddu V, Punsar S, Taylor HL, van Buchem FSP. Epidemiological studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries. Acta Med Scand. 1967;suppl:1-392.
21. Folstein MF, Folstein SE, McHugh PR. 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
22. Launer LJ. Overview of incidence studies of dementia conducted in Europe. Neuroepidemiology. 1992;11(suppl 1):2-13.
23. Fillenbaum GG, George LK, Blazer DG. Scoring nonresponse on the Mini-Mental State Examination. Psychol Med. 1988;18:1021-1025.
24. Izaks GJ, Gussekloo J, Dermout KMT, Heeren TJ, Ligthan GJ. Three-year follow-up of Mini-Mental State Examination score in community residents aged 85 and over. Psychol Med. 1995;25: 841-848.
25. Havekes L, De Knijff P, Beisiegel U, Havinga J, Smit M, Klasen E. A rapid micro-method for apolipoprotein E phenotyping directly in serum. J Lipid Res. 1987;28:445-463.
26. Rose GA, Blackburn H. Cardiovascular Survey Methods. Geneva, Switzerland: World Health Organization; 1988.
27. World Health Organization. Diabetes Mellitus: Report of a WHO Study Group. Geneva, Switzerland: World Health Organization; 1985. WHO Technical Reports Series 727.
28. Final report of the Working Group on Risk and High Blood Pressure: an epidemiological approach to describing risk associated with blood pressure levels. Hypertension. 1985;7:641-651.
29. Siedel J, Schlumberger H, Klose S, Ziegenhorn J, Wahlefeld AW. Improved reagent for the enzymatic determination of serum cholesterol. J Clin Chem Biochem. 1981;19:838-839.
30. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem. 1982;28:1379-1388.
31. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Hematol. 1957;17:237-246.
32. Ottman R. An epidemiologic approach to gene-environment interaction. Genet Epidemiol. 1990;7:177-185.
33. Rothman KJ. Modern Epidemiology. Boston, Mass: Little, Brown & Co; 1986.
34. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc. 1992;40:922-935.
35. Belle van G, Uhlmann RF, Hughes JP, Larson EB. Reliability of estimates of changes in mental status test performance in senile dementia of the Alzheimer type. J Clin Epidemiol. 1990;43: 589-595.
36. Frisoni GB, Calebresi L, Geroldi C, Bianchetti A, D'Acquarica AL, Govoni S, Sirtori CR, Trabucchi M, Franceschini G. Apolipoprotein E ε4 allele in Alzheimer's disease and vascular dementia. Dementia. 1994;5:240-242.
37. Alberts MJ, Graffagnino C, McClenny C, DeLong D, Strittmatter W, Saunders AM, Roses AD. ApoE genotype and survival from intracerebral haemorrhage. Lancet. 1995;346:575. Letter.
38. Mahley RW, Nathan BP, Bellosta S, Pitas RE. Apolipoprotein E: impact of cytoskeletal stability in neurons and the relationship to Alzheimer's disease. Curr Opin Lipidol. 1995;6:86-91.
39. Jarvik GP, Wijsman EM, Kukull WA, Schellenberg GD, Yu C, Larson EB. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Neurology. 1995;45:1092-1096.
40. Woo J, Ho SC, Chan SG, Sham A, Yuen YK, Masarei JL. Lipid profile in the Chinese old-old: comparison with younger age groups and relationship with some cardiovascular risk factors and presence of diseases. Cardiology. 1993;83:407-414.